Medeprase Mimex Private Limited - Company Profile

It is a healthcare private limited company based in Thane, Maharashtra, India, established in 2022.
2022 Thane, Maharashtra, India Active
Last Updated:
Access Report
About Medeprase Mimex Private Limited

Medeprase Mimex Private Limited, a active private limited company, was established on 13 July 2022 in Thane, Maharashtra, India. Engaging in medical appliances and instruments within the healthcare sector, it holds CIN: U33100MH2022PTC386654. Registered under ROC Roc Mumbai Ii. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Shadab Sadruddin Khan (Director), Aaliya Mohd Khalil Khan (Director). Its latest AGM occurred on 24 October 2023, with the balance sheet filed on 31 March 2023. It is based at Sh No 1/A Rassaz Greens Nr Seven Eleven High School Ramdev Park Crossing Mira Rd, Thane, Maharashtra, 401107.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33100MH2022PTC386654

  • Registration Number

    386654

  • Incorporation Date

    13 July 2022

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 3 Year, 7 Months
  • Last Filing with ROC 31 Mar 2023
Company report

Medeprase Mimex Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Medeprase Mimex Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Medeprase Mimex Private Limited?
Current Directors
Name Designation Appointment Date Status
Shadab Sadruddin Khan Director 13 Jul 2022 Current
Aaliya Mohd Khalil Khan Director 13 Jul 2022 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medeprase Mimex.

Enhance accessibility to Medeprase Mimex's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Medeprase Mimex revenue growth over time
Medeprase Mimex profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medeprase Mimex?

Unlock access to Medeprase Mimex's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Medeprase Mimex?

Unlock and access historical data on people associated with Medeprase Mimex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medeprase Mimex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medeprase Mimex's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medeprase Mimex
Recent Activity within the Organization
  • Annual General Meeting

    Medeprase Mimex Private Limited last Annual general meeting of members was held on 24 Oct 2023 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Medeprase Mimex Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai Ii. was documented.

  • Director Appointment

    Progress on Shadab Sadruddin Khan was appointed as a Director was appointed as a Director on 13 Jul 2022 & has been associated with this company since 3 years 7 months . was documented.

  • Director Appointment

    Aaliya Mohd Khalil Khan was appointed as a Director was appointed as a Director on 13 Jul 2022 & has been associated with this company since 3 years 7 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Medeprase Mimex Private Limited was registered on 13 Jul 2022 with Roc Mumbai Ii & aged 3 years 7 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Medeprase Mimex Private Limited?

The CIN of Medeprase Mimex Private Limited is U33100MH2022PTC386654.

Where is Medeprase Mimex Private Limited headquartered?

Medeprase Mimex Private Limited is headquartered at Sh No 1/A Rassaz Greens Nr Seven Eleven High School Ramdev Park Crossing Mira Rd, Thane, Maharashtra, 401107.

When was Medeprase Mimex Private Limited incorporated?

Medeprase Mimex Private Limited was incorporated on 13 July 2022.

Who are the current directors of Medeprase Mimex Private Limited?

The current directors of Medeprase Mimex Private Limited are

What is the primary industry of Medeprase Mimex Private Limited?

The primary industry of Medeprase Mimex Private Limited is Healthcare.

Is Medeprase Mimex Private Limited a listed company?

Medeprase Mimex Private Limited is unlisted.

What is the capital structure of Medeprase Mimex Private Limited?

The authorized capital of Medeprase Mimex Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available